Work

Medicación estimulante para el TDAH en el entorno escolar: Metilfenidato 30:70 / Stimulant drugs for ADHD in school settings: methylphenidate 30:70

Year: 2013
Type: review
Abstract: Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common psychiatric disorders in childhood, with an overall accumulated prevalence around 5%. It is characterized by the presence of symptoms such as inattention, impulsivity and hyperactivity. Children with ADHD show difficulties from an early age in focusing attention, control of impulsiveness and modulation of behavior. Clinical evidence suggests that, unless they reach a minimum of social competence at 8 years of age, these children will have a high probability of having social difficulties throughout his life. Treatment of ADHD consists of several strategies combined (multimodal treatment), where pharmacotherapy is prominent under different clinical practice guidelines. In the school environment, the goals of ADHD treatment focus on child adaptation to social and academic requirements by reducing the impact of core symptoms. Methylphenidate has proved effective with an adequate safety profile. Their release profile is correlated with the clinical efficacy and hence a release profile uniformly covering the 8 school hours as methylphenidate 30/70 is effective throughout the school day.
Language: Spanish
Field: Medicine
Open Access status: diamond
OpenAlex ID: W2206180129
FWCI:
Cites: 30
Cited by: 2
Related to: 9